Stock listing

OTC:ECTE Echo Therapeutics Inc Stock

Follow Echo Therapeutics Inc into a list and get an email when it puts out news.

Delisted OTC:ECTE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
OTC:ECTE
Asset type
Stock
Exchange
OTC
Currency
USD

Echo Therapeutics Inc on 6ix

Decks
3 decks · latest May 30, 2014

Decks

DeckKindSlidesDate
Proxy Contest (May 2014)Proxy contest38 slidesMay 30, 2014
Proxy Contest (May 2014)Proxy contest33 slidesMay 30, 2014
Jefferies 2013 Global Healthcare ConferenceConference16 slidesJun 7, 2013

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Charles Thomas Bernhardt III
Other companies: Cellectar Biosciences, Inc. (Interim CFO · Mar 9, 2019 – Mar 9, 2019 · Past); AIM ImmunoTech Inc. (Chief Financial Officer · Jan 1, 2009 – Dec 22, 2011 · Past)
Interim CFO · Jul 16, 2014 – Jul 16, 2014 · Past
Patrick T Mooney
Other companies: MetaStat Inc (Director · May 22, 2012 – Oct 14, 2014 · Past); Quantrx Biomedical (Director · Apr 30, 2010 – Apr 30, 2010 · Past)
CEO AND PRESIDENT, Director · Dec 31, 2009 – Oct 24, 2012 · Past
Kimberly A BurkeGENERAL COUNSEL · Oct 13, 2011 – Oct 24, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about Echo Therapeutics Inc.